Loading…
Medline Inc. is projected to rise to $48.95 by 2027, a +21% move from its current price of $40.51. MDLN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/29/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 31 | $39.42 | $40.51 | $41.62 | -0.01% |
| Aug 1 | $38.98 | $40.50 | $42.09 | -0.02% |
| Aug 2 | $38.64 | $40.50 | $42.45 | -0.03% |
| Aug 3 | $38.35 | $40.49 | $42.75 | -0.04% |
| Aug 4 | $38.11 | $40.49 | $43.02 | -0.05% |
| Aug 5 | $37.88 | $40.48 | $43.27 | -0.06% |
| Aug 6 | $37.68 | $40.48 | $43.49 | -0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $37.68 | $40.48 | $43.49 | -0.07% |
| Week 2 | $36.55 | $40.45 | $44.77 | -0.15% |
| Week 3 | $35.70 | $40.42 | $45.77 | -0.22% |
| Week 4 | $34.99 | $40.39 | $46.63 | -0.29% |
| Week 5 | $34.38 | $40.36 | $47.39 | -0.36% |
| Week 6 | $33.83 | $40.33 | $48.08 | -0.44% |
| Week 7 | $33.33 | $40.30 | $48.73 | -0.51% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Medline Inc. is a manufacturer of med-surg products serving the hospital sector, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions.
The Medline Brand segment procures and manufactures products from three product categories: surgical solutions, front line care, and laboratory and diagnostics.
Its front line care range includes med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products.
The company was founded in 1966 and is based in Northfield, Illinois.
Medline Inc. (MDLN) is currently priced at $40.51 per share, with a market cap of $72.18B, and it ranks 226 by market capitalization. The near-term technical picture shows a neutral stance with the RSI(14) at 50 and the 50-day simple moving average positioned at $37.77.
In the near term, support sits at $34.71 and resistance at $43.19, with a 30-day trading range spanning $33.88 to $48.44. The overall price outlook reflects a path of expansion in the forecast window, with projected averages rising from 2026 onward and a bullish sentiment dominating the longer horizon.
A major floor 24.2% below — a decisive break under it would weaken the trend.
The nearest floor, 14.3% below — buyers have tended to step in here.
The nearest ceiling, 6.6% above — a clean break opens room to run.
A major ceiling 19.1% above — clearing it would confirm fresh momentum.
Key MDLN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MDLN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $38.50 | Buy | $38.81 | Buy |
| MA 10 | $39.21 | Buy | $39.14 | Buy |
| MA 20 | $40.14 | Buy | $39.20 | Buy |
| MA 50 | $37.77 | Buy | $39.28 | Buy |
| MA 100 | $40.80 | Sell | $40.23 | Buy |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.13 | Neutral |
| Stoch RSI (14) | 36.74 | Neutral |
| CCI (20) | -22.22 | Neutral |
| Williams %R (14) | -56.78 | Info |
| MACD (12,26,9) | -0.31 | Sell |
| ROC (12) | -1.49 | Sell |
| Bollinger %B (20,2) | 0.43 | Neutral |
| Stochastic %K (14) | 43.22 | Neutral |
| TRIX (15) | 0.20 | Buy |
| Awesome (5,34) | 0.05 | Buy |
| Ultimate (7,14,28) | 48.83 | Neutral |
| Momentum (10) | -1.34 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 37.73 | Buy |
| ADX (14) | 13.86 | Neutral |
| ATR (14) | 1.06 | Info |
Near-term sentiment is NEUTRAL, with RSI(14) at 50. The 50-day moving average (SMA50) sits at $37.77, helping gauge near-term momentum. The current price of $40.51 trades above the SMA50, suggesting a mild positive tilt within the broader range.
Key support is at $34.71 and resistance at $43.19, framing the immediate trading band. The 30-day range runs from a low of $33.88 to a high of $48.44, outlining the most recent month of price action.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $33.19 | $40.51 | $52.68 | 0% | Neutral | |
| $37.29 | $48.95 | $68.91 | +21% | Bullish | |
| $40.08 | $55.01 | $81.59 | +36% | Bullish | |
| $44.88 | $63.92 | $98.69 | +58% | Bullish | |
| $48.06 | $70.76 | $112.96 | +75% | Bullish | |
| $47.56 | $72.21 | $118.65 | +78% | Bullish | |
| $48.40 | $75.62 | $127.48 | +87% | Bullish | |
| $48.90 | $78.53 | $135.47 | +94% | Bullish | |
| $53.87 | $88.80 | $156.46 | +119% | Bullish | |
| $62.43 | $105.56 | $189.65 | +161% | Bullish | |
| $71.09 | $135.31 | $263.54 | +234% | Bullish | |
| $131.25 | $291.67 | $637.27 | +620% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $33.19 | $40.51 | $47.60 | +0.00% |
| August 2026 | $33.20 | $39.41 | $48.20 | -2.72% |
| September 2026 | $33.39 | $40.13 | $50.02 | +1.82% |
| October 2026 | $33.91 | $41.16 | $52.09 | +2.58% |
| November 2026 | $33.23 | $40.67 | $52.11 | -1.19% |
| December 2026 | $32.97 | $40.67 | $52.68 | -0.01% |
Click any year to see its month-by-month MDLN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MDLN could reach as high as $52.68, with a base case around $40.51 and support toward $33.19 — roughly 0% from $40.51. Price action looks broadly range-bound.
Expect MDLN to range from $37.29 to $68.91 through 2027. The $48.95 average target implies a +21% move from current prices. That is up +21% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The MDLN price prediction for 2028 points to an average of $55.01 (low $40.08, high $81.59) — a potential gain of +36% on today's $40.51. Momentum favours further upside here.
In 2029, MDLN is projected to trade between $44.88 and $98.69, averaging $63.92 — a potential gain of +58% from today's $40.51. That is up +16% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Medline Inc.'s 2030 outlook centres on $70.76, within a $48.06 to $112.96 range. That is up +11% on the projected 2029 average. That marks a +75% change versus current levels. Momentum favours further upside here.
By 2031, MDLN could reach as high as $118.65, with a base case around $72.21 and support toward $47.56 — roughly +78% from $40.51. Buyers look set to stay in control over this stretch.
Expect MDLN to range from $48.40 to $127.48 through 2032. The $75.62 average target implies a +87% move from current prices. That is up +5% on the projected 2031 average. Momentum favours further upside here.
The MDLN price prediction for 2033 points to an average of $78.53 (low $48.90, high $135.47) — a potential gain of +94% on today's $40.51. Buyers look set to stay in control over this stretch.
In 2034, MDLN is projected to trade between $53.87 and $156.46, averaging $88.80 — a potential gain of +119% from today's $40.51. That is up +13% on the projected 2033 average. Momentum favours further upside here.
Medline Inc.'s 2035 outlook centres on $105.56, within a $62.43 to $189.65 range. That is up +19% on the projected 2034 average. That marks a +161% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, MDLN could reach as high as $263.54, with a base case around $135.31 and support toward $71.09 — roughly +234% from $40.51. Momentum favours further upside here.
Expect MDLN to range from $131.25 to $637.27 through 2050. The $291.67 average target implies a +620% move from current prices. That is up +116% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MDLN today (≈ 24.685263 MDLN) could be worth
$7,199.93
+$6,199.93 (+620%) by 2050 · US Dollar
Based on the average projected MDLN price of $291.67 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MDLNwould be worth at today's price.
$1,000 invested in MDLN on Dec 17, 2025 (≈ 24.390244 MDLN) would be worth
$988.05
-$11.95 (-1.2%) today · 0.99× · US Dollar
Based on a MDLN entry price of $41 vs. today's $40.51.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $38.88 | $1,041.92 | +4.2% |
| 1 month ago | $38.87 | $1,042.19 | +4.2% |
| 3 months ago | $44.24 | $915.69 | -8.4% |
| 6 months ago | $44.32 | $914.03 | -8.6% |
| All time ago | $41 | $988.05 | -1.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MDLN forecast.
Our base-case forecast reaches $81.00 around 2034.
Implied market cap at $81.00: $68.49B
The multi-year forecast shows a bullish trajectory from 2027 onward, with the 2027–2050 period delivering rising averages and higher ROI figures. In 2027 the avg is $48.95 and the max path supports further upside, culminating in 2050 with an avg of $291.67 and a max of $637.27, supported by a long-term bullish sentiment.
Looking year by year, the forecast shows 2026 with min $33.19, avg $40.51, max $52.68 (ROI 0) and sentiment NEUTRAL. From 2027 to 2035 the averages rise from $48.95 to $105.56, with year-by-year maxes climbing from $68.91 to $189.65 and ROIs moving from 20.8 to 160.6. By 2030 the avg reaches $70.76 with a 74.7 ROI, and by 2040 the avg is $135.31 with a 234 ROI.
The long-horizon view reaches 2050 with an avg of $291.67 and a 620 ROI, with sentiment staying BULLISH across 2027–2050.
Tap a question to reveal the answer.
2030 forecast: min $48.06, avg $70.76, max $112.96; ROI 74.7; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward, with rising averages and ROIs: 2027 avg $48.95 (ROI 20.8%), 2030 avg $70.76 (ROI 74.7%), 2040 avg $135.31 (ROI 234%), 2050 avg $291.67 (ROI 620%). These are estimates, not guarantees.
Yes. The 2030 max is $112.96, and the 2040 max is $263.54, with 2050 max $637.27, so surpassing $100 is indicated within the forecast path.
Current price is $40.51 and market cap is $72.18B; MDLN is ranked 226 by market capitalization.
For 2026, min $33.19, avg $40.51, max $52.68; ROI 0; sentiment NEUTRAL.
Medline Inc. Community Discussion
0Share your Medline Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.